Literature DB >> 18501873

Schistosomiasis and hepatic fibrosis regression.

Zilton A Andrade1.   

Abstract

Manson schistosomiasis is an important cause of hepatic fibrosis, a consequence of the highly fibrogenic nature of the mature schistosome eggs, the main pathogenetic factor of that disease. Thus, students interested on schistosomiasis are to be also interested on the subject of fibrosis formation and degradation since the very beginning of their studies. A brief review of the studies directly related to such interest is presented here to stress the progress obtained, and to point out to the need of further research.

Entities:  

Mesh:

Year:  2008        PMID: 18501873     DOI: 10.1016/j.actatropica.2008.04.003

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  10 in total

Review 1.  Resolution of organ fibrosis.

Authors:  Joon-Il Jun; Lester F Lau
Journal:  J Clin Invest       Date:  2018-01-02       Impact factor: 14.808

2.  Schistosomiasis mansoni: ultrasound-evaluated hepatic fibrosis and serum concentrations of hyaluronic acid.

Authors:  C C Silva; A L Domingues; E P Lopes; C N Morais; R B Santos; C F Luna; H B Nader; J R Martins
Journal:  Ann Trop Med Parasitol       Date:  2011-04

3.  New insight into the antifibrotic effects of praziquantel on mice in infection with Schistosoma japonicum.

Authors:  Yue-Jin Liang; Jie Luo; Quan Yuan; Dan Zheng; Ya-Ping Liu; Lei Shi; Ying Zhou; Ai-Ling Chen; Yong-Ya Ren; Ke-Yi Sun; Yan Sun; Yong Wang; Zhao-Song Zhang
Journal:  PLoS One       Date:  2011-05-24       Impact factor: 3.240

4.  Anti-inflammatory/anti-fibrotic effects of the hepatoprotective silymarin and the schistosomicide praziquantel against Schistosoma mansoni-induced liver fibrosis.

Authors:  Naglaa M El-Lakkany; Olfat A Hammam; Walaa H El-Maadawy; Afkar A Badawy; Afaf A Ain-Shoka; Fatma A Ebeid
Journal:  Parasit Vectors       Date:  2012-01-11       Impact factor: 3.876

5.  Association of Schistosoma mansoni-specific IgG and IgE antibody production and clinical schistosomiasis status in a rural area of Minas Gerais, Brazil.

Authors:  Deborah Negrão-Corrêa; Juliana F Fittipaldi; José Roberto Lambertucci; Mauro Martins Teixeira; Carlos Maurício de Figueiredo Antunes; Mariângela Carneiro
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

6.  Relationship between splenomegaly and hematologic findings in patients with hepatosplenic schistosomiasis.

Authors:  Luiz Arthur Calheiros Leite; Ana Lúcia Coutinho Domingues; Edmundo Pessoa Lopes; Rita de Cássia Dos Santos Ferreira; Adenor de Almeida Pimenta; Caíque Silveira Martins da Fonseca; Bianka Santana Dos Santos; Vera Lúcia de Menezes Lima
Journal:  Rev Bras Hematol Hemoter       Date:  2013

7.  Antischistosomal and anti-inflammatory activity of garlic and allicin compared with that of praziquantel in vivo.

Authors:  Dina M Metwally; Ebtesam M Al-Olayan; Mohammad Alanazi; Sanaa B Alzahrany; Abdelhabib Semlali
Journal:  BMC Complement Altern Med       Date:  2018-04-27       Impact factor: 3.659

8.  Expression of recombinant Schistosoma japonicum protein rSjE16 and its effects on LX-2 cells in vitro.

Authors:  Wenxi Gao; Wenxia Peng; Xingpei Ji; Dandan Zhu; Jinling Chen; Jinrong Feng; Yang Yu; Lian Duan; Yinong Duan
Journal:  J Int Med Res       Date:  2020-12       Impact factor: 1.671

9.  A boswellic acid-containing extract ameliorates schistosomiasis liver granuloma and fibrosis through regulating NF-κB signaling in mice.

Authors:  Miao Liu; Qingsi Wu; Peng Chen; Berthold Büchele; Maohong Bian; Shengjian Dong; Dake Huang; Cuiping Ren; Yuxia Zhang; Xin Hou; Thomas Simmet; Jijia Shen
Journal:  PLoS One       Date:  2014-06-18       Impact factor: 3.240

10.  A centenary of Robert T. Leiper's lasting legacy on schistosomiasis and a COUNTDOWN on control of neglected tropical diseases.

Authors:  J Russell Stothard; Narcis B Kabatereine; John Archer; Hajri Al-Shehri; Louis Albert Tchuem-Tchuenté; Margaret Gyapong; Amaya L Bustinduy
Journal:  Parasitology       Date:  2016-07-01       Impact factor: 3.234

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.